Why is Jagsonpal Pharma falling/rising?

As of 22-Sep, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 240.70, which reflects a decrease of 2.05 points or 0.84%. The stock has been losing value for the last two days, with a total drop of 1.47% during this period. It reached an intraday low of Rs 235, indicating a significant downward movement. Despite a strong long-term performance, with a 45.95% increase over the past year, the stock has underperformed in the short term, showing a 3.33% decline over the past week. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 23.53% compared to the five-day average, which may contribute to the stock's recent struggles.
In the broader market context, the Sensex has shown a positive return of 0.46% over the past week, contrasting with Jagsonpal's decline. This suggests that while the overall market is gaining, Jagsonpal is lagging behind. The company's fundamentals remain strong, with a low debt-to-equity ratio and consistent growth in operating profit and net sales. However, the recent drop in stock price may reflect market sentiment rather than company performance, as the stock's moving averages indicate mixed signals, being lower than the short-term averages but higher than the longer-term ones. Overall, while the company has demonstrated healthy growth and positive results over the last five quarters, the recent price movement appears to be influenced by short-term market dynamics and reduced trading activity.